JR-441

DRUG2 trials

Sponsors

Jcr Pharmaceuticals Co. Ltd., JCR Pharmaceuticals Co., Ltd.

Conditions

Mucopolysaccharidosis III-AMucopolysaccharidosis type IIIA (MPS IIIA)

Phase 1

Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA

Active, not recruitingNCT06095388

JCR Pharmaceuticals Co., Ltd.Mucopolysaccharidosis III-A

Start: 2023-10-04End: 2029-10-31Updated: 2026-09-04

Phase I/II study of weekly infusions of JR-441 in patients with mucopolysaccharidosis type IIIA

RecruitingCTIS2024-517045-14-00

Jcr Pharmaceuticals Co. Ltd.Mucopolysaccharidosis type IIIA (MPS IIIA)

Start: 2023-09-26Target: 22Updated: 2025-06-04